OGDHL regulates tumor growth, neuroendocrine marker expression, and nucleotide abundance in prostate cancer
Matthew J. Bernard, Angel Ruiz, Johnny A. Diaz, Nicholas M. Nunley, Rachel Dove, Shile Zhang, Ernie Lee, Kylie Y. Heering, Sachi Bopardikar, Andrea Gallardo, Takao Hashimoto, Raag Agrawal, Chad M. Smith, Blake R. Wilde, Nedas Matulionis, , Andrew S. Goldstein
This study identifies OGDHL as a regulator of tumor growth, neuroendocrine marker expression, and nucleotide abundance in prostate cancer, with implications for treatment resistance.
bioRxiv · May 28, 2025 · PreprintCancer Biology